Delivery Order SPE2DB22D1103-SPE2DB24FTMM4

Award Date 6/21/24
Potential Completion Date 6/24/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication, to the Defense Logistics Agency (DLA), which is a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on a firm fixed-price basis for a ceiling value of $3,864.54. The award has an ultimate completion date of July 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The firm-fixed-price delivery order has a ceiling value of $1,176.22 and an ultimate completion date of March 11, 2025. The contract is not designated under a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription insulin product, to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $2,147.93, was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,369.16 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 21, 2024 with a completion date of March 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication, to the Defense Logistics Agency (DLA). The $1,662.72 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 9, 2022, with a completion date of August 10, 2022. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,977.56 firm fixed-price delivery order contract is for the provision of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The contract has an ultimate completion date of June 23, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, through its Corporate Office division. The contract has a ceiling value of $2,113.80 and a completion date of July 16, 2024. It is a firm fixed-price delivery order contract, without any set-aside...
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription insulin medication, to the Defense Logistics Agency (DLA). The $8,835.91 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 26, 2024, with a completion date of November 27, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a division of the major pharmaceutical distributor Amerisourcebergen Corporation, is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription insulin medication, to the U.S. government. The contract has a ceiling value of $1,324.39 and is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). This award is not associated with a set-aside program....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $2,923.56 firm fixed price delivery order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription insulin medication. The award has a completion date of February 20, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTMM4
    Delivery Order

This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription insulin medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 21, 2024, with a ceiling value of $1,002.28 and a completion date of June 24, 2024.

Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific order falls under that larger IDC contract. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. The contract does not have a set-aside designation.

Generated 9/20/24, 9:42 AM